{"id":"https://openalex.org/W2151576972","doi":null,"title":"Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073.","display_name":"Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073.","alternate_titles":[],"publication_year":1991,"publication_date":"1991-05-01","ids":{"openalex":"https://openalex.org/W2151576972","mag":"2151576972","pmid":"https://pubmed.ncbi.nlm.nih.gov/1673087"},"language":"en","primary_location":{"id":"pmid:1673087","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1673087","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W2151576972"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109147794","display_name":"Wakao Sato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"W Sato","raw_affiliation_strings":["Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo","institution_ids":["https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109525866","display_name":"Nobuyuki Fukazawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Fukazawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111959710","display_name":"Tsuneji Suzuki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Suzuki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101398076","display_name":"Keisuke Yusa","orcid":"https://orcid.org/0000-0003-3392-9871","observed_orcids":["https://orcid.org/0000-0003-3392-9871"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Yusa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112511217","display_name":"Takashi Tsuruo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Tsuruo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.7268,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.90983349,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":93},"biblio":{"volume":"51","issue":"9","first_page":"2420","last_page":"2424"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multidrug-resistance-reversal","display_name":"multidrug resistance reversal","score":0.8899999856948853},{"id":"https://openalex.org/keywords/quinoline-derivatives","display_name":"quinoline derivatives","score":0.8999999761581421},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.8899999856948853},{"id":"https://openalex.org/keywords/vincristine-resistance","display_name":"vincristine resistance","score":0.8059999942779541},{"id":"https://openalex.org/keywords/doxorubicin-resistance","display_name":"doxorubicin resistance","score":0.949999988079071},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.7850000262260437},{"id":"https://openalex.org/keywords/drug-accumulation","display_name":"drug accumulation","score":0.5429999828338623},{"id":"https://openalex.org/keywords/p388-leukemia-cells","display_name":"P388 leukemia cells","score":0.7580000162124634},{"id":"https://openalex.org/keywords/k562-adm-cells","display_name":"K562/ADM cells","score":0.8820000290870667},{"id":"https://openalex.org/keywords/kb-cells","display_name":"KB cells","score":0.8169999718666077},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6639999747276306}],"concepts":[{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.7718052268028259},{"id":"https://openalex.org/C2777022698","wikidata":"https://www.wikidata.org/wiki/Q410291","display_name":"Verapamil","level":3,"score":0.7103438377380371},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.6698296070098877},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6606948375701904},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6577898263931274},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6365247964859009},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.5449967384338379},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5230125784873962},{"id":"https://openalex.org/C2777096885","wikidata":"https://www.wikidata.org/wiki/Q220925","display_name":"Vinca","level":2,"score":0.4797569513320923},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.44735774397850037},{"id":"https://openalex.org/C171122931","wikidata":"https://www.wikidata.org/wiki/Q6324626","display_name":"K562 cells","level":3,"score":0.4427894353866577},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.4118131995201111},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28239017724990845},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.279358446598053},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19018405675888062},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1772509217262268},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1634359061717987},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.09858262538909912},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.07872271537780762},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000345","descriptor_name":"Affinity Labels","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D001386","descriptor_name":"Azides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004095","descriptor_name":"Dihydropyridines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007941","descriptor_name":"Leukemia P388","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008811","descriptor_name":"Mice, Inbred DBA","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:1673087","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1673087","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Comparative Study"},{"id":"mag:2151576972","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1673087","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.328.4151","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.328.4151","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://cancerres.aacrjournals.org/content/51/9/2420.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1428720349","https://openalex.org/W1487155761","https://openalex.org/W1499732389","https://openalex.org/W1519177607","https://openalex.org/W1541814515","https://openalex.org/W1544973014","https://openalex.org/W1545285984","https://openalex.org/W1578072993","https://openalex.org/W1590812343","https://openalex.org/W1596439003","https://openalex.org/W1596954277","https://openalex.org/W1645667097","https://openalex.org/W1981999275","https://openalex.org/W1986981812","https://openalex.org/W2005877531","https://openalex.org/W2005890366","https://openalex.org/W2007181709","https://openalex.org/W2007950902","https://openalex.org/W2012306261","https://openalex.org/W2014593961","https://openalex.org/W2025603165","https://openalex.org/W2051201030","https://openalex.org/W2054432343","https://openalex.org/W2075749214","https://openalex.org/W2097336181","https://openalex.org/W2113851207","https://openalex.org/W2118069529","https://openalex.org/W2138791276","https://openalex.org/W2140927361","https://openalex.org/W2152029190","https://openalex.org/W2319974579","https://openalex.org/W2346869212"],"related_works":["https://openalex.org/W2069491451","https://openalex.org/W2088000382","https://openalex.org/W2052220068","https://openalex.org/W2996141051","https://openalex.org/W3015803772","https://openalex.org/W2108308943","https://openalex.org/W2037026342","https://openalex.org/W2030955901","https://openalex.org/W1981034185","https://openalex.org/W2002808451"],"abstract_inverted_index":{"Newly":[0],"synthesized":[1],"quinoline":[2,22],"derivatives":[3],"were":[4,117],"investigated":[5],"for":[6,96],"their":[7],"efficacy":[8],"to":[9,31,34,52,134,141,198],"reverse":[10,142],"multidrug":[11],"resistance":[12,51,72],"(MDR).":[13],"In":[14],"this":[15],"study,":[16],"one":[17],"of":[18,105,115,122,125,130,139,154,165,171],"the":[19,102,120,135],"most":[20],"effective":[21],"derivatives,":[23],"MS-073,":[24,131,187],"was":[25,144,181],"compared":[26,133],"with":[27,29,99,127,173],"verapamil":[28],"regard":[30],"its":[32],"ability":[33,138],"overcome":[35],"MDR":[36,143,192],"in":[37,40,49,55,63,73,107,112,157,160,167,177],"vitro":[38,50,64,158],"and":[39,69,87,159],"vivo.":[41,161],"MS-073":[42,92,140,150,162,190],"at":[43,148],"0.1":[44],"microM":[45,186],"almost":[46],"completely":[47,182],"reversed":[48,62],"vincristine":[53],"(VCR)":[54],"VCR-resistant":[56,108],"P388":[57],"cells.":[58,91,169],"The":[59,137],"compound":[60],"also":[61],"VCR,":[65],"adriamycin":[66],"(ADM),":[67],"etoposide,":[68],"actinomycin":[70],"D":[71],"ADM-resistant":[74,81],"human":[75,82,89],"myelogenous":[76],"leukemia":[77],"K562":[78],"(K562/ADM)":[79],"cells,":[80,86],"ovarian":[83],"carcinoma":[84],"A2780":[85],"colchicine-resistant":[88],"KB":[90],"administered":[93],"i.p.":[94],"daily":[95],"5":[97],"days":[98],"VCR":[100,106,126],"enhanced":[101,163],"chemotherapeutic":[103],"effect":[104],"P388-bearing":[109],"mice.":[110],"Increases":[111],"life":[113],"span":[114],"19-50%":[116],"obtained":[118],"by":[119,184,193],"combination":[121],"100":[123],"micrograms/kg":[124],"3-100":[128],"mg/kg":[129],"as":[132],"control.":[136],"remarkably":[145],"higher,":[146],"especially":[147],"low":[149],"doses,":[151],"than":[152],"that":[153,189],"verapamil,":[155],"both":[156],"accumulation":[164],"[3H]VCR":[166],"K562/ADM":[168,178],"Photolabeling":[170],"P-glycoprotein":[172],"200":[174],"nM":[175],"[3H]azidopine":[176],"plasma":[179],"membranes":[180],"inhibited":[183],"10":[185],"indicating":[188],"reverses":[191],"competitively":[194],"inhibiting":[195],"drug":[196],"binding":[197],"P-glycoprotein.":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2151576972","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
